Genotoxicity of lomefloxacin - An antibacterial drug in somatic and germ cells of Swiss albino mice in vivo

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 535, Issue 1, 2003, Pages 35-42

  Singh, Akhilesh C ^a   Kumar, Mithilesh ^a   Jha, Anand M ^a  

^a Samastipur College   (India)

Author keywords

Chromosomal aberration; Difluorinated quinolone; Dominant lethal mutation; Genotoxicity; Lomefloxacin

Indexed keywords

LOMADAY; LOMEFLOXACIN;

ANIMAL CELL; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; FEMALE; GENOTOXICITY; GERM CELL; IN VIVO STUDY; MALE; MATING; METAPHASE; MITOSIS INDEX; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; SOMATIC CELL; TOXICITY TESTING;

ANIMALS; ANTI-INFECTIVE AGENTS; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; FEMALE; FERTILITY; FLUOROQUINOLONES; GENES, DOMINANT; GENES, LETHAL; MALE; MICE; MUTAGENICITY TESTS; MUTAGENS; MUTATION; OVUM; QUINOLONES; SPERMATOZOA;

EID: 0037419752     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(02)00284-X     Document Type: Article

References (52)

1. Monk J.P., Campoli-Richards D.M. Ofloxacin, review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 33:1987;346-351.
2. Fisher L.M., Lawrence J.M., Josty I.C., Hopewell R., Margerrison E.E.C. Ciprofloxacin and the fluoroquinolones; new concepts on the mechanism of action and resistance. Am. J. Med. 87:1989;25-85.
3. Cook T., Goss W., Deitz W. Mechanism of action of nalidixic acid on Eschrechia coli. J. Bacteriol. 191:1966;780-783.
4. German A., Panouse-Perrin J., Ardovin A. Mutagenic action of nalidixic acid on Escherichia coli. II. Inhibition of deoxyribonucleic acid synthesis. J. Bacteriol. 89:1969;1068-1074.
5. Yoshikawa M. Drug sensitivity and mutability to drug associated with the presence of an R factor. Genet. Res. Camb. 17:1971;1-7.
6. Kada T., Tutikawa K., Sadi Y. In vitro and host-mediated "rec-assay" procedure for screening chemical mutagens and phloxine, a mutagenic red dye detected. Mutat. Res. 16:1972;165-174.
7. Burnie J., Burnie R. Ciprofloxacin. Drug Future. 9:1984;179-182.
8. Mc Queen C.A., Way B.M., Queeney S.M., Schluter G., Williams G.M. Study of potential in vitro and in vivo genotoxicity in hepatocytes of quinolone antibiotics. Toxicol. Appl. Pharmacol. 111:1991;255-262.
9. Bredberg A., Brant M., Riesbeck K., Azou Y., Frosgren A. 4-Quinolone antibiotics: positive genotoxic screening test despite an apparent lack of mutation induction. Mutat. Res. 211:1989;171-180.
10. Holden H.E., Barett J.F., Hutington C.M., Muehebauer P.A., Wahrenburg M.G. Genetic profile of nalidixic acid and analog: a model for the mechanism of sister chromatid exchange induction. Environ. Mol. Mutagen. 13:1989;238-252.
11. Bredberg A., Brant M., Jaszyk M. Ciprofloxacin-induced inhibition of topoisomerase II in human lymphoblastoid cells. Antimicrob. Agents Chemother. 35:1991;448-450.
12. Ciaravinco V., Suto M.J., Theiss J.C. High capacity in vitro micronucleus assay for assessment of chromosome damage, results with quinolone/naphthyridone antibacterials. Mutat. Res. 298:1993;227-236.
13. Curry P.J., Kropko M.L., Garvin J.R., Fiedler R.D., Theiss J.C. In vitro induction of micronuclei and chromosomal aberrations by quinolones: possible mechanism. Mutat. Res. 352:1996;143-150.
14. Gibson D.P., Mo X., Switzer A.G., Murphy V.A., Aardema M.J. Comparative genotoxicity of quinolone and quinolonyl - lactam antibacterials in the in vitro micronucleus assay in Chinese hamster ovary cells. Environ. Mol. Mutagen. 31:1998;345-351.
15. Shimada H., Itoh S., Halton G., Tada S., Matsura Y. Mutagenicity of levofloxacin, a new quinolone antibacterial agent. Arzeniem. Forsch. 47:1996;378-385.
16. Mamber S.W., Brookshire K.W., Kolek B., Fung-tomc J. Evaluation of the DNA-reactive and mutagenic potential of quinolones in microbial system. Environ. Mol. Mutagen. 19:1992;40.
17. Fort F.L. Mutagenicity of quinolone antibacterials. Drug Safety. 7:1992;214-222.
18. Stenchever M., Powell W., Jarvis J. Effect of nalidixic acid on human chromosome integrity. Am. J. Obstet. Gynecol. 107:1970;329-330.
19. Shimada H., Morita H., Akimoto T. Lack of induction of dominant lethal mutation in male mice by nalidixic acid. Toxicol. Lett. 7:1980;165-174.
20. Itoh S., Miura M., Shimada H. Lack of mutagenicity of levofloxacin in lacZ transgenic mice. Mutagenesis. 13:1998;51-55.
21. Herbold B.A., Brendler-Shcwaab S.Y., Ahr H.J. Ciprofloxacin, in vivo genotoxicity studies. Mutat. Res. 498:2001;193-205.
22. Klecak G., Urbach F., Urwyler H. Fluoroquinolone antibacterials enhance UVA-induced skin tumors. J. Photochem. Photobiol. B: Biol. 37:1997;174-181.
23. Mäkiminen M., Forbes P.D., stenbäck F. Quinolone antibacterials: a new class of photochemical carcinogens. J. Photochem. Photobiol. B: Biol. 37:1997;182-187.
24. Preston R.J., Dean B.D., Galloway S., Holden H., Macfee A.F., Shelby M. Mammalian in vivo cytogenetic assay, analysis of chromosomal aberrations in bone marrow cells. Mutat. Res. 189:1987;157-165.
25. Krishna G., Petrere J., Anderson J., Theiss J. Use of cyclophosphamide as a positive control in dominant lethal and micronucleus assays. Mutat. Res. 335:1995;331-337.
26. Tice R.R., Boucher R., Luke C.A., Shelby M. Comparative cytogenetic analysis of bone marrow damage induced in male B6C3F mice by multiple exposure to gaseous 1,3-butadiene. Environ. Mutagen. 9:1987;235-250.
27. Ehling U.H., Machemer L., Husselmair W., Dyoka J., Frobberg H., Kratochvilova J., Lang R., Larke D., Muller D., Pult J., Rohrborn G., Roll R., Schulzeschenking M., Wickmann H. Standard protocol for the dominant lethal test on male mice. Arch. Toxicol. 39:1978;173-185.
28. Mc Queen C.A., Williams G.M. Effects of quinolone antibiotics in test for genotoxicity. Am. J. Med. 82:1987;94-96.
29. Shimada H., Itoh S., Halton G., Tada S., Matsura Y. Mutagenicity of levofloxacin, a new quinolone antibacterial agent. Arzeniem. Forsch. 47:1992;378-385.
30. Albertini S., Chaetelat A.A., Miller B., Muster W., Pujadas E., Strobel R., Gocke E. Genotoxicity of 17 gyrase and four mammalian topoisomerase II poisons in prokaryotic and eukaryotic test systems. Mutagenesis. 10:1995;343-351.
31. Gellert M., Mizuuchi K., O'Dean M., Itoh J. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc. Natl. Acad. Sci. U.S.A. 74:1977;4772-4776.
32. Cozzaretti N. DNA gyrase and the supercoiling of DNA. Science. 207:1980;953-960.
33. Castora T., Vissering F., Simpson M. The effect of bacterial DNA gyrase inhibitors on DNA synthesis in mammalian mitochondria. J. Biol. Chem. 254:1983;11193-11195.
34. Robinson M.J., Martin B.J., D Gootz T., McGuirk P.R., Moynihan M., Sutcliffe J.A., Csheroff N. Effects of quinolone derivatives on eukaryotic topoisomerase II: a novel mechanism for enhancement of enzyme mediated DNA cleavage. J. Biol. Chem. 266:1991;14585-14592.
35. Rasquet R., Bonhommet M., David J.C. Quinolone antibiotics inhibit eukaryotic DNA polymerase α- and β-terminal deoxynucleotidyl transferase but not DNA ligase. Biochem. Biophys. Res. Commun. 121:1984;762-769.
36. R.K. Ralph, W. Judd, Y. Polemier, K.W. Kohn, DNA topoisomerase, in: S. Neidle, M. Waring (Eds.), Topics in Molecular and Structural Biology: Molecular Aspects of Anticancer Drug-DNA Interaction, 1st ed., vol. 2, 1994, Macmillan, London, pp. 1-95.
37. Ferguson L.R., Baguley B. Topoisomerase II enzymes and mutagenicity. Environ. Mol. Mutagen. 24:1994;245-261.
38. Shimada H. Photogenotoxicity of fluoroquinolone antibacterial agents. Environ. Mutagen. Res. 23(2):2001;83-88.
39. Chaetelat A.A., Albertini S., Gocke E. The photogenotoxicity of fluoroquinolones in the test for gene mutation, chromosomal aberrations, gene conversion and DNA breakage (comet assay). Mutagenesis. 11(5):1996;497-504.
40. Bulera S.J., Theiss J.C., Festerling T.A., de la Igtesic F.A. In vitro photogenotoxic activity of clinafloxacin: a paradigm predicting photocarcinogenicity. Toxicol. Appl. Pharmacol. 156(3):1999;222-230.
41. Kersten B., Zhang J., Brendler-Schwabb S.Y., Kasper P., Mouller L. The application of micronucleus test in Chinese hamster V79 cells to detect drug induced photogenotoxicity. Mutat. Res. 445(1):1999;55-71.
42. Synder R.D., Cooper C.S. Photogenotoxicity of fluoroquinolones in Chinese hamster V79 cells: dependency on active topoisomerase II. Photochem. Photobiol. 69(3):1999;288-293.
43. Marrot L., Belaids J.P., Chauta C., Mennier J.R., Perez P., Agapakis-Causse C. Fluoroquinolones as chemical tools to define strategy for photogenotoxicity in vitro assessment. Toxicol. In Vitro. 15(2):2001;131-142.
44. Zhang J., Kersten B., Kasper P., Mulero L. Photogenotoxicity and apoptosis in human HaCaT keratinocytes induced by 8- methoxypsoralen and lomefloxacin. Environ. Mutagen. Res. 23(2):2001;89-96.
45. Itoh S., Nakayama S., Shimada H. In vitro photochemical clastogenicity of quinolone antibacterial agents studied by a chromosomal aberration test with light irradiation. Mutat. Res. GTEM. 517(1-2):2002;113-121.
46. International Commission for Protection Against Environmental Mutagens and Carcinogens 1983, Report of Committee 1. Mutat. Res. 114 (1983) 120-177.
47. Rosen J.E., Prahalad A.K., Schluter G., Chen D., Williams G.H. Quinolone antibiotic photodynamic production of 8-oxo-7,8-dihydro-2′-deoxyguanosine in cultured liver epithelial cells. Photochem. Photobiol. 65:1997;990-996.
48. Umezawa N., Arakane K., Ryu A., Mashiko S. Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents. Arch. Biochem. Biophys. 342:1997;275-281.
49. World Health Organization 1985, Environmental Health Criteria 51, Guide to Short-term Tests for Detecting Mutagenic and Carcinogenic Chemicals, WHO, Geneva, pp. 100-114.
50. Shelby M.D., Bishop J.B., Mason J.M., Tindell K.R. Fertility, reproduction and genetic disease: studies on the reproductive effects of environmental agents on mammalian germ cells. Environ. Health Perspect. 100:1993;283-291.
51. I.D. Adler, Male germ cell cytogenetics, in: T.C. Hsu (Ed.), Cytogenetic Assays of Environmental Mutagens, Allenheld Osmum, Totowa, NJ, 1982, pp. 249-276.
52. Preston R.J., Fenne T.R., Leber P., Sielken R.L. Jr., Swenberg J.A. Recommendation of the genetic risk assessment for ethylene oxide exposure. J. Environ. Mol. Mutagen. 20:1995;189-202.